Soleus Capital Management, L.P. Alector, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Alector, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 1,207,371 shares of ALEC stock, worth $2.23 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
1,207,371
Previous 2,239,006
46.08%
Holding current value
$2.23 Million
Previous $10.2 Million
44.54%
% of portfolio
0.48%
Previous 1.03%
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
168Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$10.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$8.57 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$8.06 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$5.05 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $153M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...